This analysis describes what Writer's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
The updated terms establish clearer scope (these terms apply to free, trial, and paid versions; Enterprise is separate) and expand the list of prohibited uses. Users may no longer reverse engineer, scrape, or attempt to derive components of the Services; use the platform for competitive analysis or to develop competing products; or misrepresent AI-generated output as human-created. The terms also explicitly prohibit processing of HIPAA-regulated health information. Users can review the full updated terms to understand which specific uses are now restricted.
View change record →How other platforms handle this
OPENAI'S AFFILIATES, SUPPLIERS, LICENSORS, AND DISTRIBUTORS ARE INTENDED THIRD PARTY BENEFICIARIES OF THIS SECTION.
Teladoc Health disclaims any and all liability for any information, including but without limitation, any medical and health treatment information set forth on linked sites.
we will not be liable or responsible for any loss or damage of any sort incurred as the result of any correspondence or dealing solely between you any third party.
"Beta Features are not intended for production use, and we have no liability for any harm or damage arising out of or in connection with your use of Beta Features.Excerpt from Writer's Terms of Service
Get the weekly coverage letter
Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.
The clause states: “Beta Features are not intended for production use, and we have no liability for any harm or damage arising out of or in connection with your use of Beta Features.”
ConductAtlas has identified this type of provision across 281 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Writer.